| Literature DB >> 23074379 |
Daniel J Heidenberg1, Joel H Barton, Denise Young, Michael Grinkemeyer, Isabell A Sesterhenn.
Abstract
Neural-cadherin is a member of the cadherin gene family encoding the N-cadherin protein that mediates cell adhesion. N-cadherin is a marker of Sertoli cells and is also expressed in germ cells of varying stages of maturation. The purpose of this study was to determine the presence and distribution of this protein by immunohistochemistry in 105 germ cell tumors of both single and mixed histological types and 12 gonadal stromal tumors. Twenty-four germ cell tumors consisted of one cell type and the remaining were mixed. Of the 23 seminomas in either pure or mixed tumors, 74% were positive. Two spermatocytic seminomas were positive. Of the 83 cases with yolk sac tumor, 99% were positive for N-cadherin. The teratomas were positive in 73% in neuroectodermal and / or glandular components. In contrast, 87% of embryonal carcinomas did not express N-cadherin. Only 17% of the syncytiotrophoblastic cells were positive for N-cadherin. In conclusion, N-cadherin expression is very helpful in the identification of yolk sac tumors. In addition to glypican-3 and Sal-like protein 4, N-cadherin can be beneficial for the diagnosis and classification of this subtype of testicular germ cell tumor. Nine of the 12 gonadal stromal tumors were positive to a variable extent.Entities:
Keywords: N-cadherin; germ cell tumors; gonadal stromal tumors.; testis
Year: 2012 PMID: 23074379 PMCID: PMC3471079 DOI: 10.7150/jca.5017
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Frequency of Histological Tumor Types.
| Tumor Type | Number |
|---|---|
| Seminoma | 8 |
| Yolk Sac Tumor (1 metastatic) | 7 |
| Teratoma (1 metastatic) | 4 |
| Embryonal Carcinoma | 3 |
| Spermatocytic Seminoma | 2 |
| Yolk Sac Tumor, Embryonal Carcinoma, Teratoma | 22 |
| Yolk Sac Tumor, Embryonal Carcinoma, Teratoma, Syncytiotrophoblasts | 14 |
| Yolk Sac Tumor, Embryonal Carcinoma | 12 |
| Yolk Sac Tumor, Teratoma | 9 |
| Yolk Sac Tumor, Embryonal Carcinoma, Syncytiotrophoblasts | 4 |
| Yolk Sac Tumor, Embryonal Carcinoma, Teratoma, Seminoma | 3 |
| Yolk Sac Tumor, Teratoma, Seminoma, | 3 |
| Yolk Sac Tumor, Embryonal Carcinoma, Seminoma, Syncytiotrophoblasts | 3 |
| Yolk Sac Tumor, Embryonal Carcinoma, Seminoma | 2 |
| Yolk Sac Tumor, Embryonal Carcinoma, Teratoma, Seminoma, Syncytiotrophoblasts | 2 |
| Seminoma, Embryonal Carcinoma | 2 |
| Yolk Sac Tumor, Teratoma, Choriocarcinoma | 1 |
| Yolk Sac Tumor, Embryonal Carcinoma, Choriocarcinoma | 1 |
| Teratoma, Syncytiotrophoblasts | 1 |
| Embryonal Carcinoma, Teratoma, Choriocarcinoma | 1 |
| Embryonal Carcinoma, Teratoma | 1 |
| Sertoli Cell Tumor | 6 |
| Leydig Cell Tumor | 4 |
| Sertoli- Leydig Cell Tumor | 1 |
| Juvenile Granulosa Tumor | 1 |
N-cadherin Expression in Pure Germ Cell Tumors.
| Tumor | Extent of Tumor Positive (no. of tumors) | Intensity of Staining | ||||||
|---|---|---|---|---|---|---|---|---|
| Pure Tumors | 0 | 1-25% | 26-50% | 51-75% | 76-100% | 1+ | 2+ | 3+ |
| Seminoma (8) | 2 | 5 | 1 | 0 | 0 | 2 | 4 | 0 |
| Yolk Sac Tumor (6) | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 6 |
| Teratoma (3)* | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
| Spermatocytic Seminoma (2) | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 |
| Embryonal Carcinoma (3) | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
* Due to the glandular and glial staining of teratoma, we were unable to calculate percentage of tumor stained.
N-cadherin Protein Expression in Mixed Germ Cell Tumors.
| Tumor | Extent of Tumor Positive (no. of tumors) | Intensity of Staining | ||||||
|---|---|---|---|---|---|---|---|---|
| Mixed Germ Cell Tumors | 0 | 1-25% | 26-50% | 51-75% | 76-100% | 1+ | 2+ | 3+ |
| Yolk Sac Tumor (76) | 1 | 10 | 6 | 10 | 49 | 8 | 16 | 51 |
| Embryonal Carcinoma (67) | 59 | 8 | 0 | 0 | 0 | 4 | 3 | 1 |
| Teratoma* (57) | 15 | 0 | 0 | 0 | 0 | 16 | 18 | 8 |
| Seminoma (15) | 4 | 5 | 4 | 0 | 2 | 4 | 7 | 0 |
| Choriocarcinoma (3) | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Syncytiotrophoblasts (24) | 20 | 4 | 0 | 0 | 0 | 4 | 0 | 0 |
* Due to the glandular and glial staining of teratoma, we were unable to calculate percentage of tumor stained.
Fig 1A: Immature testis with seminiferous tubules in the upper half and rete in the lower half (H&E x 10). B same field (anti N-cadherin x 10). Sertoli cells and rete epithelium are positive in a membranous pattern. Some of the spermatogonia may also be positive.
Fig 2A: Adult testis (H&E x 20). On the right seminiferous tubules with spermatogenesis are seen. The left shows a tubule with intratubular germ cell neoplasia unclassified. The Leydig cells are prominent. The insert shows persistent immature tubules lined by strongly positive Sertoli cells ( H&E x 40). B: same field (anti-N-cadherin x 20). Sertoli cells are positive, and a number of spermatogonia and spermatocytes may be positive. The intratubular malignant germ cells and the Sertoli cells have a membranous reaction. The Leydig cells are negative. The insert shows persistent immature tubules lined by strongly positive Sertoli cells (anti N-cadherin x40).
Fig 3A: Epididymal ducts (H&E x 20). B: same field (anti N-cadherin x 20). Epithelial cells with membranous reactivity.
Fig 4A: Seminoma with entrapped seminiferous tubule in upper center (H&E x 20). B: same field (anti N-cadherin x 40). The tumor cells show a linear zipper-like positive reaction.
Fig 5A: Spermatocytic seminoma (H&E x 20). B: same field (anti N-cadherin x 20). Many of the tumor cells show the zipper-like membranous staining.
Fig 6A: Yolk sac tumor with reticular and microcystic growth pattern (H&E stain x 20). B: same field (anti N-cadherin x 20). The tumor cells show cytoplasmic and membranous staining.
Fig 8A: The tumor consists of embryonal carcinoma (*), yolk sac tumor (long arrow), and syncytiotrophoblastic cells (short arrow) (H&E x 20). B: same field (N-cadherin x 20). The embryonal carcinoma (*) is negative, whereas the yolk sac tumor elements (long arrow) and some of the syncytiotrophoblastic cells (short arrow) are positive.
Fig 7A: Embryonal carcinoma (H&E x 20). B: same field (anti N-cadherin x 20). A number of tumor cells show cytoplasmic and membranous reactivity. C: Embryonal carcinoma (H&E x 40). D: same field (anti N-cadherin x 40). A small cluster of tumor cells shows “disorganized” incomplete partial cytoplasmic and membranous reactivity.
Fig 9A: Mixed germ cell tumor consisting of immature teratoma with neuroectodermal elements (short arrow), yolk sac tumor (long arrow), and enteric glands. (H&E x 20). B: same field (anti N-cadherin x 20). The neuroectodermal elements (short arrow), enteric gland, and yolk sac tumor (long arrow) are positive.
Fig 10A: Leydig cell tumor (H&E x 20). B: same field (anti N-cadherin x 20). Note the focal membranous staining.
Fig 11A: Sertoli cell tumor (H&E x 20). Note the tubular formation. B: same field (anti N-cadherin). The tumor cells show membranous staining.
N-cadherin Expression in Stromal Tumors.
| Tumor | Extent of Tumor Positive (no. of tumors) | Intensity of Staining | ||||||
|---|---|---|---|---|---|---|---|---|
| Stromal Tumors | 0 | 1-25% | 26-50% | 51-75% | 76-100% | 1+ | 2+ | 3+ |
| Sertoli Cell Tumor (6) | 2 | 3 | 1 | 0 | 0 | 3 | 1 | 0 |
| Leydig Cell Tumor (4) | 1 | 3 | 0 | 0 | 0 | 3 | 0 | 0 |
Fig 12A: Juvenile granulosa cell tumor (H&E x 20). B: same field (anti N-cadherin). The staining is membranous and cytoplasmic.